← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $4.6M of United Therapeutics Corporation

Sold$4,647,354
$489.20Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Sep 8Copier in Sep 9
The stock from Wed, Sep 9 open, $502.75
+8.0%
S&P 500, same days
+0.3%

28 of 30 trading days so far, to the Oct 19 close.

Traded Fri, Sep 4. Filed Tue, Sep 8, 4:31 PM ET, after the close. Returns use the Sep 9 open and the Oct 19 close. Not investment advice.